Neo Ivy Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Neo Ivy Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$383K	Buy	+17,910	New	+$382K	0.26%	177

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Neo Ivy Capital Management's ISEE Position: Q4 2022 in Review

Neo Ivy Capital Management opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022: 17,910 shares worth $383K. The stake represents 0.26% of the portfolio and ranks #177 among its holdings.

225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

Neo Ivy Capital Management held 17,910 shares of IVERIC bio, Inc. Common Stock worth $383K as of Q4 2022.
IVERIC bio, Inc. Common Stock was a new Neo Ivy Capital Management position in Q4 2022.
IVERIC bio, Inc. Common Stock made up 0.26% of Neo Ivy Capital Management's portfolio in Q4 2022, its #177 holding.
225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Neo Ivy Capital Management's 13F filing for Q4 2022, filed 27 Mar 2023.